A panel of 10 expert hematologists created recommendations for optimal MRD-guided ALL treatment, which were recently ...

This Double Take video from the New England Journal of Medicine describes a man with recurrent severe diffuse abdominal pain without obvious associated symptoms. Based on a Clinical Problem ...

Blinatumomab 的商品名是Blincyto，俗称blina，是一种生物制药药物，用于治疗费城染色体阴性的复发或难治性急性淋巴细胞白血病的二线治疗。它属于一类合成单克隆抗体，即双特异性 T 细胞接合器(BiTE)，可选择性地发挥作用并指示人体免疫系统对抗肿瘤细胞。

The National Institute for Health and Care Excellence (NICE) has recommended blinatumomab with chemotherapy for National Health Service (NHS) use in adults with aggressive leukaemia. The ...

This innovative treatment, known as blinatumomab (Blincyto), is set to benefit approximately 80 adults per year and will be available immediately on the NHS. Blinatumomab represents a major ...

NEW YORK – The UK's National Institute for Health and Care Excellence (NICE) on Friday approved Amgen's Blincyto (blinatumomab) with chemotherapy as a consolidation treatment for adult patients with ...

will be available immediately on the NHS. The treatment, called blinatumomab (also known as Blincyto), works in a completely new way. It helps the body's own immune system recognise and destroy cancer ...

Separately, NICE has also recommended the use of Blincyto (blinatumomab), a bispecific T-cell engager (BiTE) therapy from Amgen. The treatment is for adults with CD19-positive B-cell precursor acute ...